Dfe Pharma India Llp
Founded: 2011
Status: Converted To Cmp And Dissolved
Designation: Designated Partner
CS
Chakrapani Saikrishnan - Profile
Chakrapani Saikrishnan, Designated Partner and Director, with 5 companies across 1 industry.
About
Chakrapani Saikrishnan
Chakrapani Saikrishnan has 9 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Dfe Pharma India Llp and Crest Cellulose Private Limited. Formerly with 3 companies, such as Crest Cellulose Private Limited and Dfe Pharma India Private Limited. Engaged in General Business. Contributes to corporate operations.
Current Companies
2
Past Companies
3
Total Affiliations
5
Oldest Company Age
14
Companies Associated with Chakrapani Saikrishnan
Current Companies
Crest Cellulose Private Limited
Founded: 2012
Status: Active
Designation: Director
Previous Companies
Crest Cellulose Private Limited
Founded: 2012
Status: Active
Designation: Additional Director
Dfe Pharma India Private Limited
Founded: 2019
Status: Active
Designation: Director
Dfe Pharma India Llp
Founded: 2011
Status: Converted To Cmp And Dissolved
Designation: Partner
Explore Director's current and past company associations— Uncover their professional journey today!
Frequently Asked Questions
Who is Chakrapani Saikrishnan?
Chakrapani Saikrishnan has 9 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Dfe Pharma India Llp and Crest Cellulose Private Limited. Formerly with 3 companies, such as Crest Cellulose Private Limited and Dfe Pharma India Private Limited. Engaged in General Business. Contributes to corporate operations.
What is Chakrapani Saikrishnan's role in current companies?
Chakrapani Saikrishnan is associated with 2 companies as Designated Partner and Director.
What industries does Chakrapani Saikrishnan specialize in?
Chakrapani Saikrishnan has expertise in General Business.
How many years of experience does Chakrapani Saikrishnan have?
Chakrapani Saikrishnan has 9 years in corporate governance.